e-learning
resources
London 2016
Wednesday, 07.09.2016
Translational research in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vasculotide reduced pulmonary hyperpermeability in pneumococcal pneumonia
Birgitt Gutbier (Berlin, Germany), Birgitt Gutbier, Xiaohui Jiang, Carolin Ehrler, Tim J. Mitchell, Norbert Weissmann, Paul Van Slyke, Dan J. Dumont, Norbert Suttorp, Martin Witzenrath
Source:
International Congress 2016 – Translational research in respiratory infections
Session:
Translational research in respiratory infections
Session type:
Oral Presentation
Number:
4990
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Birgitt Gutbier (Berlin, Germany), Birgitt Gutbier, Xiaohui Jiang, Carolin Ehrler, Tim J. Mitchell, Norbert Weissmann, Paul Van Slyke, Dan J. Dumont, Norbert Suttorp, Martin Witzenrath. Vasculotide reduced pulmonary hyperpermeability in pneumococcal pneumonia. Eur Respir J 2016; 48: Suppl. 60, 4990
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Aerobic exercise inhibits pseudomonas aeruginosa-induced acute lung injury in elderly mice
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013
Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Outcome of high-flow nasal cannula for acute hypoxemic respiratory failure due to pneumocystis pneumonia
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Obstructive pulmonary disease with acute respiratory failure
Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11
Year: 2001
Predictors of failure of noninvasive ventilation in acute cardiogenic pulmonary edema
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Markers of sudden cardiac arrest in patients with severe respiratory infections
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept